Integrating Serum Lipid Biomarkers Into Machine Learning for the Differential Diagnosis of Breast Nodules.

Objective: To develop and validate an interpretable machine learning (ML) model for predicting malignant risk in patients with breast nodules using serum lipid biomarkers. Methods: This retrospective study included 899 patients with breast nodules (236 malignant) admitted between March 2022 and Dece...

Descripción completa

Detalles Bibliográficos
Publicado en:Breast Journal Vol. 2026; pp. 1 - 13
Autores principales: Chen, Longmei, Du, Yuzhen, Liu, Wanchao, Dattachoudhury, Sreeja
Formato: research tables/charts Journal Article
Publicado: Wiley-Blackwell 8/21/2026
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=196384953&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 196384953
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        1075122X
        ET6
      jtl: Breast Journal
      issn: 1075122X
      maglogo: Y
    pubinfo:
      dt: 8/21/2026
      vid: 2026
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        196384953
        196384953
        196384953
        10.1155/tbj/2642494
        196384953
      ppf: 1
      ppct: 12
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: C
          – @attributes:
              type: P
      tig:
        atl: Integrating Serum Lipid Biomarkers Into Machine Learning for the Differential Diagnosis of Breast Nodules.
      aug:
        au:
          Chen, Longmei
          Du, Yuzhen
          Liu, Wanchao
          Dattachoudhury, Sreeja
        affil: Department of Laboratory Medicine,, Shanghai Baoshan Hospital of Integrated Traditional Chinese and Western Medicine,, Baoshan Hospital,, Shanghai University of Traditional Chinese Medicine,, Shanghai 201999,, China, shutcm.edu.cn
      sug:
        subj:
          Lipids Blood
          Tumor Markers, Biological Blood
          Diagnosis, Differential
          Breast Neoplasms Diagnosis
          Prediction Models Evaluation
          Breast Neoplasms Risk Factors
          Risk Assessment
          Machine Learning
          Human
          Retrospective Design
          Record Review
          Calibration
          ROC Curve
          Random Forest
          Age Factors
          Decision Support Systems, Clinical
          China
          Antigens, Tumor Blood
          Ferritin Blood
          Machine Learning Algorithms
          Female
          Descriptive Statistics
          Funding Source
          Female
      ab: Objective: To develop and validate an interpretable machine learning (ML) model for predicting malignant risk in patients with breast nodules using serum lipid biomarkers. Methods: This retrospective study included 899 patients with breast nodules (236 malignant) admitted between March 2022 and December 2024. Patients were randomly assigned to a training cohort (n = 630) and an internal validation cohort (n = 269) at a 7:3 ratio. Baseline clinical and laboratory data were collected upon admission. Following feature selection via LASSO regression, the predictive performance of 8 ML algorithms was evaluated and compared using receiver operating characteristic (ROC) curves. The optimal model's performance was further corroborated using an independent temporal validation cohort of 190 patients (admitted Jan–Aug 2025). Model interpretability was addressed using SHapley Additive exPlanations (SHAP). Results: Nine key predictors were identified from 20 candidates by Lasso regression and clinical expertise. The random forest (RF) model outperformed other algorithms, achieving areas under the curve (AUC) values of 0.789, 0.782, and 0.825 for the training, internal validation, and temporal validation cohorts, respectively. Hosmer–Lemeshow tests (p > 0.05) indicated high calibration between the predicted and observed risks. SHAP importance analysis revealed Fer, age, and CEA to be the top three predictive factors. Conclusion: The RF model based on serum lipid biomarkers serves as a robust, noninvasive tool for assessing breast cancer risk, showing significant potential for clinical decision support in screening programs.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N